COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020

Because of in vitro studies, hydroxychloroquine has been evaluated as a preexposure or postexposure prophylaxis for coronavirus disease (COVID-19) and as a possible COVID-19 curative treatment. We report a case of COVID-19 in a patient with sarcoidosis who was receiving long-term hydroxychloroquine...

Descripció completa

Dades bibliogràfiques

Autors principals:	François Bénézit, Audrey Le Bot, Stéphane Jouneau, Florian Lemaître, Charlotte Pronier, Pierre-Axel Lentz, Solène Patrat-Delon, Matthieu Revest, Vincent Thibault, Pierre Tattevin
Format:	Artigo
Idioma:	Inglês
Publicat:	Centers for Disease Control and Prevention 2020-10-01
Col·lecció:	Emerging Infectious Diseases
Matèries:	COVID-19 2019 novel coronavirus disease hydroxychloroquine plasma concentration sarcoidosis France
Accés en línia:	https://wwwnc.cdc.gov/eid/article/26/10/20-1816_article
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!